Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma

Dysregulation of fibroblast growth factor receptor 3 (FGFR3) by the translocation t(4;14)(p16;q32) occurs in 15% of multiple myeloma (MM) patients and confer...